Detection and manipulation of live antigen-expressing cells using conditionally stable nanobodies

  1. Jonathan CY Tang
  2. Eugene Drokhlyansky
  3. Behzad Etemad
  4. Stephanie Rudolph
  5. Binggege Guo
  6. Sui Wang
  7. Emily G Ellis
  8. Jonathan Z Li
  9. Constance L Cepko  Is a corresponding author
  1. Howard Hughes Medical Institute, Harvard Medical School, United States
  2. Harvard Medical School, United States

Abstract

The ability to detect and/or manipulate specific cell populations based upon the presence of intracellular protein epitopes would enable many types of studies and applications. Protein binders such as nanobodies (Nbs) can target untagged proteins (antigens) in the intracellular environment. However, genetically expressed protein binders are stable regardless of antigen expression, complicating their use for applications that require cell-specificity. Here, we created a conditional system in which the stability of an Nb depends upon an antigen of interest. We identified Nb framework mutations that can be used to rapidly create destabilized Nbs. Fusion of destabilized Nbs to various proteins enabled applications in living cells, such as optogenetic control of neural activity in specific cell types in the mouse brain, and detection of HIV-infected human cells by flow cytometry. These approaches are generalizable to other protein binders, and enable the rapid generation of single-polypeptide sensors and effectors active in cells expressing specific intracellular proteins.

Article and author information

Author details

  1. Jonathan CY Tang

    Departments of Genetics and Ophthalmology, Howard Hughes Medical Institute, Harvard Medical School, Boston, United States
    Competing interests
    Jonathan CY Tang, Submitted a patent application regarding destabilized nanobodies. International Application No. PCT/US2016/027749 Priority: US Prov. Appl. No. 62/148,595.
  2. Eugene Drokhlyansky

    Departments of Genetics and Ophthalmology, Howard Hughes Medical Institute, Harvard Medical School, Boston, United States
    Competing interests
    Eugene Drokhlyansky, Submitted a patent application regarding destabilized nanobodies. International Application No. PCT/US2016/027749Priority: US Prov. Appl. No. 62/148,595.
  3. Behzad Etemad

    Brigham and Women's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  4. Stephanie Rudolph

    Department of Neurobiology, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  5. Binggege Guo

    Departments of Genetics and Ophthalmology, Howard Hughes Medical Institute, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  6. Sui Wang

    Departments of Genetics and Ophthalmology, Howard Hughes Medical Institute, Harvard Medical School, Boston, United States
    Competing interests
    Sui Wang, Submitted a patent application regarding destabilized nanobodies. International Application No. PCT/US2016/027749Priority: US Prov. Appl. No. 62/148,595.
  7. Emily G Ellis

    Department of Neurobiology, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  8. Jonathan Z Li

    Brigham and Women's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  9. Constance L Cepko

    Departments of Genetics and Ophthalmology, Howard Hughes Medical Institute, Harvard Medical School, Boston, United States
    For correspondence
    cepko@genetics.med.harvard.edu
    Competing interests
    Constance L Cepko, Submitted a patent application regarding destabilized nanobodies. International Application No. PCT/US2016/027749 Priority: US Prov. Appl. No. 62/148,595.

Reviewing Editor

  1. Liqun Luo, Howard Hughes Medical Institute, Stanford University, United States

Ethics

Animal experimentation: The Institutional Animal Care and Use Committee at Harvard Medical School approved all animal experiments conducted under protocols 428-R98, 04537 and 1493.

Version history

  1. Received: February 17, 2016
  2. Accepted: May 19, 2016
  3. Accepted Manuscript published: May 20, 2016 (version 1)
  4. Version of Record published: June 27, 2016 (version 2)

Copyright

© 2016, Tang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 9,090
    views
  • 1,770
    downloads
  • 80
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jonathan CY Tang
  2. Eugene Drokhlyansky
  3. Behzad Etemad
  4. Stephanie Rudolph
  5. Binggege Guo
  6. Sui Wang
  7. Emily G Ellis
  8. Jonathan Z Li
  9. Constance L Cepko
(2016)
Detection and manipulation of live antigen-expressing cells using conditionally stable nanobodies
eLife 5:e15312.
https://doi.org/10.7554/eLife.15312

Share this article

https://doi.org/10.7554/eLife.15312

Further reading

    1. Developmental Biology
    Siyuan Cheng, Ivan Fan Xia ... Stefania Nicoli
    Research Article

    Vascular smooth muscle cells (VSMCs) envelop vertebrate brain arteries and play a crucial role in regulating cerebral blood flow and neurovascular coupling. The dedifferentiation of VSMCs is implicated in cerebrovascular disease and neurodegeneration. Despite its importance, the process of VSMC differentiation on brain arteries during development remains inadequately characterized. Understanding this process could aid in reprogramming and regenerating dedifferentiated VSMCs in cerebrovascular diseases. In this study, we investigated VSMC differentiation on zebrafish circle of Willis (CoW), comprising major arteries that supply blood to the vertebrate brain. We observed that arterial specification of CoW endothelial cells (ECs) occurs after their migration from cranial venous plexus to form CoW arteries. Subsequently, acta2+ VSMCs differentiate from pdgfrb+ mural cell progenitors after they were recruited to CoW arteries. The progression of VSMC differentiation exhibits a spatiotemporal pattern, advancing from anterior to posterior CoW arteries. Analysis of blood flow suggests that earlier VSMC differentiation in anterior CoW arteries correlates with higher red blood cell velocity and wall shear stress. Furthermore, pulsatile flow induces differentiation of human brain PDGFRB+ mural cells into VSMCs, and blood flow is required for VSMC differentiation on zebrafish CoW arteries. Consistently, flow-responsive transcription factor klf2a is activated in ECs of CoW arteries prior to VSMC differentiation, and klf2a knockdown delays VSMC differentiation on anterior CoW arteries. In summary, our findings highlight blood flow activation of endothelial klf2a as a mechanism regulating initial VSMC differentiation on vertebrate brain arteries.

    1. Developmental Biology
    Zhimin Xu, Zhao Wang ... Yingchuan B Qi
    Research Article

    Precise developmental timing control is essential for organism formation and function, but its mechanisms are unclear. In C. elegans, the microRNA lin-4 critically regulates developmental timing by post-transcriptionally downregulating the larval-stage-fate controller LIN-14. However, the mechanisms triggering the activation of lin-4 expression toward the end of the first larval stage remain unknown. We demonstrate that the transmembrane transcription factor MYRF-1 is necessary for lin-4 activation. MYRF-1 is initially localized on the cell membrane, and its increased cleavage and nuclear accumulation coincide with lin-4 expression timing. MYRF-1 regulates lin-4 expression cell-autonomously and hyperactive MYRF-1 can prematurely drive lin-4 expression in embryos and young first-stage larvae. The tandem lin-4 promoter DNA recruits MYRF-1GFP to form visible loci in the nucleus, suggesting that MYRF-1 directly binds to the lin-4 promoter. Our findings identify a crucial link in understanding developmental timing regulation and establish MYRF-1 as a key regulator of lin-4 expression.